iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Endowus
Singapore
- Singapore
- 09/08/2023
- Unknown
- $35,000,000
Endowus is a Singapore-based financial technology company that empowers people to take control of their financial future. The firm’s proprietary systems provide data-driven wealth advice in constructing personalised solutions. Its portfolios are built on access to institutional-quality financial products at the lowest cost possible.
Endowus is a fee-only independent advisor paid solely by its clients, allowing its advice to be unaffected by conflicts of interest. The firm provides its end-to-end digital solution to individual and institutional investors. It is licensed by the Monetary Authority of Singapore.
- Industry Financial Services
- Website https://endowus.com/
- LinkedIn https://www.linkedin.com/company/endowus/about/
Related People
Samuel RheeCo Founder
Singapore -
Singapore
Sam is Co-founder, Chairman & CIO at Endowus, the largest independent digital wealth platform in Asia with over U$5B of client assets and over U$95M of funding from some of the leading institutional investors and Asian families. It is the first digital advisor for Singapore's national social security system - the CPF, and the only digital wealth platform that allows you to invest your personal savings, private wealth and public pension in a seamless app experience. Endowus leads the proliferation of independent, conflict-free, fee-only financial advice in the region. He has three decades of experience in investing and finance and was formerly the CEO & Chief Investment Officer at Morgan Stanley Investment Management in Asia.
Quorus | $5,000,000 | (Mar 18, 2026)
BambooBox | $6,600,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
SEQUENTIAL | $3,500,000 | (Mar 18, 2026)
Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Tenkara | $7,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)